LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Dasatinib | 10.0 | uM | LJP6 | 72 | hr | 1311 | 677 | 5013 | 0.1351 | -0.1714 |
MDA-MB-231 | Dovitinib | 10.0 | uM | LJP5 | 72 | hr | 1311 | 2027 | 5013 | 0.4044 | 0.1934 |
MDA-MB-231 | Enzastaurin | 10.0 | uM | LJP5 | 72 | hr | 1311 | 5142 | 5013 | 1.0258 | 1.0349 |
MDA-MB-231 | Erlotinib | 10.0 | uM | LJP5 | 72 | hr | 1311 | 3708 | 5013 | 0.7397 | 0.6475 |
MDA-MB-231 | Foretinib | 10.0 | uM | LJP5 | 72 | hr | 1311 | 787 | 5013 | 0.1570 | -0.1417 |
MDA-MB-231 | R406 | 10.0 | uM | LJP6 | 72 | hr | 1311 | 1817 | 5013 | 0.3624 | 0.1365 |
MDA-MB-231 | Pictilisib | 10.0 | uM | LJP6 | 72 | hr | 1311 | 2597 | 5013 | 0.5181 | 0.3473 |
MDA-MB-231 | Gefitinib | 10.0 | uM | LJP6 | 72 | hr | 1311 | 4569 | 5013 | 0.9114 | 0.8800 |
MDA-MB-231 | Geldanamycin | 10.0 | uM | LJP5 | 72 | hr | 1311 | 786 | 5013 | 0.1568 | -0.1420 |
MDA-MB-231 | Geldanamycin | 10.0 | uM | LJP6 | 72 | hr | 1311 | 797 | 5013 | 0.1591 | -0.1389 |
MDA-MB-231 | GSK1059615 | 10.0 | uM | LJP5 | 72 | hr | 1311 | 2194 | 5013 | 0.4377 | 0.2384 |
MDA-MB-231 | GSK1059615 | 10.0 | uM | LJP6 | 72 | hr | 1311 | 2064 | 5013 | 0.4118 | 0.2034 |
MDA-MB-231 | GSK1904529A | 10.0 | uM | LJP6 | 72 | hr | 1311 | 4531 | 5013 | 0.9038 | 0.8697 |
MDA-MB-231 | Omipalisib | 10.0 | uM | LJP6 | 72 | hr | 1311 | 626 | 5013 | 0.1250 | -0.1851 |
MDA-MB-231 | GSK 690693 | 10.0 | uM | LJP5 | 72 | hr | 1311 | 4646 | 5013 | 0.9267 | 0.9007 |
MDA-MB-231 | GW843682X | 10.0 | uM | LJP6 | 72 | hr | 1311 | 1137 | 5013 | 0.2269 | -0.0471 |
MDA-MB-231 | HG-5-113-01 | 10.0 | uM | LJP5 | 72 | hr | 1311 | 1318 | 5013 | 0.2629 | 0.0017 |
MDA-MB-231 | HG-5-88-01 | 10.0 | uM | LJP6 | 72 | hr | 1311 | 2950 | 5013 | 0.5884 | 0.4426 |
MDA-MB-231 | Imatinib | 10.0 | uM | LJP6 | 72 | hr | 1311 | 4460 | 5013 | 0.8897 | 0.8507 |
MDA-MB-231 | JNK-9L | 10.0 | uM | LJP6 | 72 | hr | 1311 | 960 | 5013 | 0.1915 | -0.0950 |
MDA-MB-231 | JW-7-24-1 | 10.0 | uM | LJP6 | 72 | hr | 1311 | 1172 | 5013 | 0.2338 | -0.0377 |
MDA-MB-231 | Lapatinib | 10.0 | uM | LJP6 | 72 | hr | 1311 | 3377 | 5013 | 0.6736 | 0.5580 |
MDA-MB-231 | LDN-193189 | 10.0 | uM | LJP5 | 72 | hr | 1311 | 641 | 5013 | 0.1279 | -0.1811 |
MDA-MB-231 | Linifanib | 10.0 | uM | LJP6 | 72 | hr | 1311 | 2666 | 5013 | 0.5318 | 0.3658 |
MDA-MB-231 | Linsitinib | 10.0 | uM | LJP5 | 72 | hr | 1311 | 4148 | 5013 | 0.8274 | 0.7663 |